8-K - LENZ Therapeutics, Inc. (0001815776) (Filer)
Published . Updated .
8-K - LENZ Therapeutics filed an 8-K with the SEC on Oct 28 (a notice of a material company event).
Directly affected
- LENZ LENZ Therapeutics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that LENZ Therapeutics belongs to, so it often moves with news about it.
- AMGN Amgen+19.0% 30d
Amgen is a peer of LENZ Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+8.7% 30d
Gilead Sciences is a peer of LENZ Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+35.5% 30d
Moderna is a peer of LENZ Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-16.8% 19d
argenx SE is a peer of LENZ Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of LENZ Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LENZ | +1.73% | -1.41% | base | +9.26% | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AMGNNo price data for this ticker | — | — | — | — | — | — | — |
| GILDNo price data for this ticker | — | — | — | — | — | — | — |
| MRNANo price data for this ticker | — | — | — | — | — | — | — |
| ARGXNo price data for this ticker | — | — | — | — | — | — | — |
| RVMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-28 AccNo: 0001815776-26-000056 Size: 304 KB Item 2.02: Results of Operations and Financial Condition Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election…
Source: sec-edgar
LENZ Therapeutics (LENZ) since “8-K - LENZ Therapeutics, Inc. (0001815776) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| LENZ Therapeutics (LENZ) | that day | +9.26% | final price |
| LENZ Therapeutics (LENZ) | three days earlier | -1.41% | final price |
| LENZ Therapeutics (LENZ) | five days earlier | +1.73% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 36 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 63 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 77 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 79 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 61 days before publication. Filed 8 Oct 2026. View the filing.
- Scott A Kupor, an executive branch official, sold Revolution Medicines (RVMD), worth $1,001 - $15,000 on 30 Jul 2026. That is 90 days before publication. Filed 30 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - LENZ Therapeutics, Inc. (0001815776) (Filer)”
Companies tied to this story
- LENZ LENZ Therapeutics
In “8-K - LENZ Therapeutics, Inc. (0001815776) (Filer),” LENZ Therapeutics (LENZ) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> LENZ
How “8-K - LENZ Therapeutics, Inc. (0001815776) (Filer)” reaches LENZ Therapeutics (LENZ)
The 28 Oct 2026 story “8-K - LENZ Therapeutics, Inc. (0001815776) (Filer)” names LENZ Therapeutics (LENZ) because of this story.
LENZ Therapeutics (LENZ) is on the page because SEC 8-K filing -> direct issuer disclosure -> LENZ
The price range for LENZ Therapeutics (LENZ), and the dates in the story
LENZ traded between 3.08 and 3.21 across 1 sessions. The latest close on file is 3.18.
How strong the case is around LENZ Therapeutics (LENZ)
14 out of 100
“8-K - LENZ Therapeutics, Inc. (0001815776) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.